Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Tuberculosis (Edinb). 2012 Nov 3;93(2):192–197. doi: 10.1016/j.tube.2012.10.003

Table 3.

Effect of serum heat-inactivation on M. tuberculosis association with monocytes from participants with and without diabetes

Diabetes classification PID M. tuberculosis association (% monocytes infected)
Fraction of association attributed to heat-labile factora P values
Fresh serum Heat-inactivated serum Fresh serum Heated serum Association due to heat-labile factor
No DM 5–133 31.2 6.9 78% REF REF REF
No DM 5–135 21.0 3.0 86%
No DM 5–141 32.0 19.5 39%
No DM 5–147 29.0 0.0 100%
No DM 5–149 39.5 8.9 77%
No DM 5–153 17.5 6.0 66%

Mean (SD) 28.4(8) 7.4(6.7) 74.3%(20.6)

DMb 5–134 24.9 6.0 76% 0.04 0.69 0.06
DMb 5–137 31.0 9.0 71%
DMb 5–143 23.5 9.0 62%
DMb 5–150 12.0 6.0 50%
DMp 5–101 11.9 9.2 23%
DMp 5–114 10.4 7.1 32%
DMp 5–139 19.0 17.0 11%
DMp 5–140 20.0 12.5 38%
DMp 5–142 23.5 5.5 77%
DMp 5–146 22.0 4.0 82%

Mean (SD) 17.8(5.4) 10.1(5) 37.6%(33)

Mycobacteria was added at a 10:1 MOI in 20% fresh or heated autologous serum for 2h (see Methods);

a

Fraction of association=1-(%monocyte association in Heat-inactivated serum/%monocyte association in fresh serum);

DMb, diabetes with borderline glucose control; DMp, diabetes with poor glucose control; PID, participant identification; M. tuberculosis, M. tuberculosis.